Our Portfolio & Innovation in Pharma, Biotech, Nutra and NRT

At SRK Pharmaceuticals, we are redefining diabetes care through innovation, precision, and patient-centric solutions. Our insulin portfolio is built on decades of R&D expertise, state-of-the-art biotechnology, and a commitment to affordability and global accessibility.

Diverse Insulin Portfolio

  • Rapid-acting insulins for postprandial glucose control

  • Long-acting insulins for 24-hour basal coverage

  • Premixed formulations for optimized dosing convenience

  • Biosimilar insulins with global regulatory compliance

Pharmaceuticals

  • Solid oral dosage forms (tablets, capsules – IR/SR/CR)

  • Injectables (lyophilized, prefilled syringes, vials)

  • Topicals and dermatological formulations

  • Complex generics and fixed-dose combinations
    Regulatory Reach: USFDA, EMA, MHRA, WHO-GMP

Nutraceuticals (Nutra)

  • Immunity boosters, adaptogens, antioxidants

  • Probiotics, prebiotics, and synbiotics

  • Functional supplements for metabolic, cognitive, and gut health

  • Effervescent, gummy, and sachet-based innovations